These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


110 related items for PubMed ID: 9366029

  • 1. Steady-state pharmacokinetics of the enantiomers of citalopram and its metabolites in humans.
    Sidhu J, Priskorn M, Poulsen M, Segonzac A, Grollier G, Larsen F.
    Chirality; 1997; 9(7):686-92. PubMed ID: 9366029
    [Abstract] [Full Text] [Related]

  • 2. Metabolism of citalopram enantiomers in CYP2C19/CYP2D6 phenotyped panels of healthy Swedes.
    Herrlin K, Yasui-Furukori N, Tybring G, Widén J, Gustafsson LL, Bertilsson L.
    Br J Clin Pharmacol; 2003 Oct; 56(4):415-21. PubMed ID: 12968986
    [Abstract] [Full Text] [Related]

  • 3. Protein binding of indobufen enantiomers: pharmacokinetics of free fraction-studies after single or multiple doses of rac-indobufen.
    Główka FK, Caldwell J.
    Chirality; 2002 Oct; 14(9):736-41. PubMed ID: 12237835
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of reboxetine enantiomers in the dog.
    Frigerio E, Benecchi A, Brianceschi G, Pellizzoni C, Poggesi I, Strolin Benedetti M, Dostert P.
    Chirality; 1997 Oct; 9(3):303-6. PubMed ID: 9176997
    [Abstract] [Full Text] [Related]

  • 5. Steady-state pharmacokinetics of indobufen enantiomers in patients with obliterative atherosclerosis.
    Glówka FK, Strzelecka D, Zapalski S.
    Chirality; 2001 Jun; 13(6):308-12. PubMed ID: 11370020
    [Abstract] [Full Text] [Related]

  • 6. Steady-state pharmacokinetics of propranolol enantiomers in healthy male volunteers.
    Paradiso-Hardy FL, Walker SE, Bowles SK.
    Int J Clin Pharmacol Ther; 1998 Jul; 36(7):370-5. PubMed ID: 9707351
    [Abstract] [Full Text] [Related]

  • 7. Cytochrome P450-dependent disposition of the enantiomers of citalopram and its metabolites: in vivo studies in Sprague-Dawley and Dark Agouti rats.
    Kingbäck M, Carlsson B, Ahlner J, Bengtsson F, Kugelberg FC.
    Chirality; 2011 Feb; 23(2):172-7. PubMed ID: 20848647
    [Abstract] [Full Text] [Related]

  • 8. Steady-state concentration of venlafaxine enantiomers: model-based analysis of between-patient variability.
    Gex-Fabry M, Rudaz S, Balant-Gorgia AE, Brachet A, Veuthey JL, Balant LP, Bertschy G.
    Eur J Clin Pharmacol; 2002 Aug; 58(5):323-31. PubMed ID: 12185556
    [Abstract] [Full Text] [Related]

  • 9. Stereoselective single-dose kinetics of citalopram and its metabolites in rats.
    Kugelberg FC, Carlsson B, Ahlner J, Bengtsson F.
    Chirality; 2003 Aug; 15(7):622-9. PubMed ID: 12840828
    [Abstract] [Full Text] [Related]

  • 10. Sustained citalopram treatment in experimental hepatic encephalopathy: effects on entrainment to the light-dark cycle and melatonin.
    Kugelberg FC, Apelqvist G, Carlsson B, Ahlner J, Bengtsson F.
    Basic Clin Pharmacol Toxicol; 2006 Jul; 99(1):80-8. PubMed ID: 16867175
    [Abstract] [Full Text] [Related]

  • 11. Effects of diltiazem on the disposition and metabolism of the enantiomers of propranolol in the dog during multiple oral dosing.
    Lankford SM, Maskasame C, Bai SA.
    Drug Metab Dispos; 1994 Jul; 22(5):776-87. PubMed ID: 7835231
    [Abstract] [Full Text] [Related]

  • 12. A population pharmacokinetic model for R- and S-citalopram and desmethylcitalopram in Alzheimer's disease patients with agitation.
    Akil A, Bies RR, Pollock BG, Avramopoulos D, Devanand DP, Mintzer JE, Porsteinsson AP, Schneider LS, Weintraub D, Yesavage J, Shade DM, Lyketsos CG.
    J Pharmacokinet Pharmacodyn; 2016 Feb; 43(1):99-109. PubMed ID: 26611790
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of citalopram in relation to the sparteine and the mephenytoin oxidation polymorphisms.
    Sindrup SH, Brøsen K, Hansen MG, Aaes-Jørgensen T, Overø KF, Gram LF.
    Ther Drug Monit; 1993 Feb; 15(1):11-7. PubMed ID: 8451774
    [Abstract] [Full Text] [Related]

  • 14. Enantioselectivity in the steady-state pharmacokinetics of metoprolol in hypertensive patients.
    Cerqueira PM, Cesarino EJ, Mateus FH, Mere Y, Santos SR, Lanchote VL.
    Chirality; 1999 Feb; 11(7):591-7. PubMed ID: 10423287
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics and pharmacodynamics of methadone enantiomers in hospice patients with cancer pain.
    Auret K, Roger Goucke C, Ilett KF, Page-Sharp M, Boyd F, Oh TE.
    Ther Drug Monit; 2006 Jun; 28(3):359-66. PubMed ID: 16778720
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of S- and R-enantiomers of aminoglutethimide following oral administration of racemic drug in breast cancer patients.
    Alshowaier IA, el-Yazigi A, Ezzat A, Abd el-Warith A, Nicholls PJ.
    J Clin Pharmacol; 1999 Nov; 39(11):1136-42. PubMed ID: 10579143
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of enantiomers of trans-tramadol and its active metabolite, trans-O-demethyltramadol, in human subjects.
    Liu HC, Liu TJ, Yang YY, Hou YN.
    Acta Pharmacol Sin; 2001 Jan; 22(1):91-6. PubMed ID: 11730570
    [Abstract] [Full Text] [Related]

  • 18. Influence of tobacco smoke on the pharmacokinetics of citalopram and its enantiomers.
    Majcherczyk J, Kulza M, Senczuk-Przybylowska M, Florek E, Jawien W, Piekoszewski W.
    J Physiol Pharmacol; 2012 Feb; 63(1):95-100. PubMed ID: 22460466
    [Abstract] [Full Text] [Related]

  • 19. Citalopram: interaction studies with levomepromazine, imipramine, and lithium.
    Gram LF, Hansen MG, Sindrup SH, Brøsen K, Poulsen JH, Aaes-Jørgensen T, Overø KF.
    Ther Drug Monit; 1993 Feb; 15(1):18-24. PubMed ID: 8451775
    [Abstract] [Full Text] [Related]

  • 20. Analysis of the enantiomers of citalopram and its demethylated metabolites using chiral liquid chromatography.
    Kosel M, Eap CB, Amey M, Baumann P.
    J Chromatogr B Biomed Sci Appl; 1998 Nov 20; 719(1-2):234-8. PubMed ID: 9869386
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.